loading

Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.54%
29.33
30.10 32.42 38.55 35.71
Operating Income/Loss
2.54%
-29.33
-30.10 -32.42 -38.55 -35.71
Nonoperating Income/Loss
11.70%
2.346
2.657 3.067 3.303 3.762
Income/Loss From Continuing Operations Before Tax
1.65%
-26.99
-27.44 -29.32 -35.25 -31.95
Income/Loss From Continuing Operations After Tax
1.65%
-26.99
-27.44 -29.32 -35.25 -31.95
Net Income/Loss
1.65%
-26.99
-27.44 -29.35 -35.25 -31.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.09%
71.20
71.13 0.7832 70.67 70.55
Diluted Average Shares
0.09%
71.20
71.13 0.7832 70.67 70.55
Basic Earnings Per Share
2.56%
-0.38
-0.39 -0.41 -0.50 -0.45
Diluted Earnings Per Share
2.56%
-0.38
-0.39 -0.41 -0.50 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):